Adma Biologics Inc Receita T/T
Qual é o Receita T/T de Adma Biologics Inc?
O Receita T/T de Adma Biologics Inc é 78.29%
Qual é a definição de Receita T/T?
O crescimento trimestral da receita, ano após ano, é o aumento da receita de uma empresa em comparação com o desempenho no trimestre correspondente do ano anterior, expresso como uma porcentagem.
Quaterly revenue growth is the amount by which revenue exceeds the revenue in a previous quarter. It is beneficial to look at a company's quarterly financials to identify how the company is performing over time not just during the current period. The usage of year over year comparison is advantageous in removing seasonalities in reporting the quarterly revenue growth and observing longterm trends.
Receita T/T de empresas na Setor Health Care em NASDAQ em comparação com Adma Biologics Inc
O que Adma Biologics Inc faz?
adma is a late-stage biopharmaceutical company that develops, manufactures and intends to commercialize specialty plasma-based biologics for the treatment and prevention of primary immune deficiency disease (pidd) and certain infectious diseases. adma's mission is to develop and commercialize plasma-derived, human immune globulins targeted to niche patient populations for the treatment and prevention of certain infectious diseases. the target patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disease, or who may be immune-compromised for medical reasons. adma’s lead product candidate, ri-002, has completed a phase iii clinical trial in patients with pidd and has met the primary endpoint. a bla for ri-002 was accepted by the fda on september 18, 2015. the company has received u.s. patent 9,107,906. for more information, please visit the company's website at www.admabiologics.com.
Empresas com receita t/t semelhantes a Adma Biologics Inc
- Great Portland Estates Plc tem Receita T/T de 78.02%
- Ansal Housing & Construction tem Receita T/T de 78.07%
- Dealnet Capital tem Receita T/T de 78.07%
- Orient Bell tem Receita T/T de 78.16%
- Alfen N.V tem Receita T/T de 78.19%
- Catella AB (publ) tem Receita T/T de 78.26%
- Adma Biologics Inc tem Receita T/T de 78.29%
- Dhunseri Investments tem Receita T/T de 78.39%
- Sterling Consolidated tem Receita T/T de 78.49%
- Sreeleathers tem Receita T/T de 78.52%
- Tantech Ltd tem Receita T/T de 78.56%
- Vikas EcoTech tem Receita T/T de 78.56%
- Masimo tem Receita T/T de 78.68%